Literature DB >> 31571165

SLC Family Transporters.

Xiaodong Liu1.   

Abstract

Solute carrier (SLC) family transporters utilize an electrochemical potential difference or an ion gradient generated by primary active transporters for transporting their substrates across biological membranes. These transporters are categorized as facilitated transporters or secondary active transporters. More than 300 SLC transporters have been identified. SLC transporters related to drug transport mainly include SLC21 gene subfamily (organic anion-transporting polypeptides, OATPs), SLC22A gene subfamily (organic anion transporters, OATs; organic cation transporters, OCTs; or organic cation/carnitine transporters, OCTNs), SLC15A gene subfamily (peptide transporters, PEPTs), and SLC47A gene subfamily (multidrug and toxin extrusion, MATEs). In general, OCTs transport organic cations, OATPs transport large and fairly hydrophobic organic anions, OATs transport the smaller and more hydrophilic organic anions, and PEPTs are responsible for the uptake of di-/tripeptides and peptide-like drugs. MATEs are responsible for efflux of organic cations. These transporters also transport some endogenous substances, indicating that the dysfunction of SLCs not only disrupts homeostasis but also largely impacts on the disposition of their substrate drugs. This chapter will discuss these SLC family transporters, with an emphasis on tissue distribution, substrate specificity, transporter physiology, and clinical significance.

Entities:  

Keywords:  Multidrug and toxin extrusion; Organic anion transporters; Organic anion-transporting polypeptides; Organic cation transporters; Organic cation/carnitine transporters; Peptide transporters; Solute carrier

Mesh:

Substances:

Year:  2019        PMID: 31571165     DOI: 10.1007/978-981-13-7647-4_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  12 in total

1.  Antiapoptotic Clone 11-Derived Peptides Induce In Vitro Death of CD4+ T Cells Susceptible to HIV-1 Infection.

Authors:  Anastassia Mikhailova; José Carlos Valle-Casuso; Annie David; Valérie Monceaux; Stevenn Volant; Caroline Passaes; Amal Elfidha; Michaela Müller-Trutwin; Jean-Luc Poyet; Asier Sáez-Cirión
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

2.  Transcriptional Regulation of Solute Carrier (SLC) Drug Transporters.

Authors:  Shiwei Zhou; Yan Shu
Journal:  Drug Metab Dispos       Date:  2022-05-29       Impact factor: 3.579

3.  Prediction of Cyclosporin-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Model Characterizing Interplay of Drug Transporters and Enzymes.

Authors:  Yiting Yang; Ping Li; Zexin Zhang; Zhongjian Wang; Li Liu; Xiaodong Liu
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923

4.  Diabetes downregulates peptide transporter 1 in the rat jejunum: possible involvement of cholate-induced FXR activation.

Authors:  Li-Min Liang; Jun-Jie Zhou; Feng Xu; Pei-Hua Liu; Lan Qin; Li Liu; Xiao-Dong Liu
Journal:  Acta Pharmacol Sin       Date:  2020-04-27       Impact factor: 7.169

5.  Family-effects in the epigenomic response of red blood cells to a challenge test in the European sea bass (Dicentrarchus labrax, L.).

Authors:  Madoka Vera Krick; Erick Desmarais; Athanasios Samaras; Elise Guéret; Arkadios Dimitroglou; Michalis Pavlidis; Costas Tsigenopoulos; Bruno Guinand
Journal:  BMC Genomics       Date:  2021-02-09       Impact factor: 3.969

6.  A pan-cancer analysis revealed the role of the SLC16 family in cancer.

Authors:  Jun Li; Jiaheng Xie; Dan Wu; Liang Chen; Zetian Gong; Rui Wu; Yiming Hu; Jiangning Zhao; Yetao Xu
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

7.  A Pan-Cancer Analysis of SLC12A5 Reveals Its Correlations with Tumor Immunity.

Authors:  Yi Jiang; Hong-Li Liao; Li-Ya Chen
Journal:  Dis Markers       Date:  2021-09-29       Impact factor: 3.434

Review 8.  Imbalance of Drug Transporter-CYP450s Interplay by Diabetes and Its Clinical Significance.

Authors:  Yiting Yang; Xiaodong Liu
Journal:  Pharmaceutics       Date:  2020-04-11       Impact factor: 6.321

Review 9.  The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes.

Authors:  Douglas B Kell
Journal:  Molecules       Date:  2021-09-16       Impact factor: 4.411

10.  Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma.

Authors:  Jiaheng Xie; Zhechen Zhu; Yuan Cao; Shujie Ruan; Ming Wang; Jingping Shi
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.